Skip to main navigation Skip to search Skip to main content

Discovery and optimization of indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2-3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy.

Research output: Contribution to journalLiterature reviewpeer-review

Search results